Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/16/2012US20120040925 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
02/16/2012US20120040924 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
02/16/2012US20120040923 Stable s-adenosyl-l-methionine
02/16/2012US20120040922 Antibiotic macrocycle compounds and methods of manufacture and use thereof
02/16/2012US20120040921 Compositions and products containing s-equol, and methods for their making
02/16/2012US20120040920 Oligosaccharide aldonic acids and their topical use
02/16/2012US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
02/16/2012US20120040916 Molecular inhibitors of the wnt/beta-catenin pathway
02/16/2012US20120040914 Enhancing effectiveness of glial cancer therapies
02/16/2012US20120040906 Protein targets in disease
02/16/2012US20120040904 Boronate Medicaments for Preventing Thrombosis During Surgery
02/16/2012US20120040901 Novel biomaterials, their preparation and use
02/16/2012US20120040898 Pharmaceutical compositions
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040896 Compositions, methods and uses for modulation of brca 1
02/16/2012US20120040888 Anti-infective hydroxy-phenyl-benzoates and methods of use
02/16/2012US20120040887 Composition for the treatment of osteomyelitis, method for preparing the same, and method for the treatment of osteomyelitis
02/16/2012US20120040075 Package drink
02/16/2012US20120040033 Anti-infective mangrove extract against viruses, bacteria and fungi
02/16/2012US20120040025 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
02/16/2012US20120040022 Gallium compositions for the treatment of liver cancer and methods of use
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120040019 Medicated ointment for treating hemorrhoid and method of using the same
02/16/2012US20120040016 Brimonidine compositions for treating erythema
02/16/2012US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120040011 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
02/16/2012US20120040009 Particulate pharmaceutical composition with an opioid and an opioid antagonist
02/16/2012US20120040008 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012US20120040007 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
02/16/2012US20120040006 Pharmaceutical Compositions Comprising Brivaracetam
02/16/2012US20120040004 Treatment of radiation-induced fibrosis
02/16/2012US20120040003 Anti-dandruff compositions with citrus fibers
02/16/2012US20120040002 Resorbable and biocompatible fibre glass compositions and their uses
02/16/2012US20120039999 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012US20120039997 Methods of treating hypertriglyceridemia
02/16/2012US20120039995 Arsenic compounds, their preparation methods and uses thereof
02/16/2012US20120039991 Use of apoptosis inhibiting compounds in degenerative neurological disorders
02/16/2012US20120039990 Liposome Compositions and Methods of Use Thereof
02/16/2012US20120039988 Cancer-targeting peptides and uses thereof in cancer therapy
02/16/2012US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039983 Amphiphilic macromolecule-lipid complexes
02/16/2012US20120039981 Chewing Gum And Particulate Material For Controlled Release Of Active Ingredients
02/16/2012US20120039970 Ready-to-use, stable suspension of partially amorphous carotenoid particles
02/16/2012US20120039969 Swellable dosage form comprising gellan gum
02/16/2012US20120039964 Novel formulations of fat-soluble active ingredients with high bioavailability
02/16/2012US20120039963 3-(2-Dimethlaminomethyl Cyclohexyl)Phenol Retard Formulation
02/16/2012US20120039962 Pharmaceutical Compositions
02/16/2012US20120039960 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
02/16/2012US20120039958 Compositions and methods for treatment of taupathy
02/16/2012US20120039957 Optimized niacin compositions in pharmaceutical products
02/16/2012US20120039954 Method of treating insomnia
02/16/2012US20120039953 Riluzole aqueous suspensions
02/16/2012US20120039947 Methods and compositions for treating psoriasis
02/16/2012US20120039945 Methods Of Immune Modulation
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
02/16/2012US20120039912 Rspondin-3 inhibition in bone disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039909 Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039903 Methods for suppressing an immune response or treating a proliferative disorder
02/16/2012US20120039894 Identification of therapeutic agents for hiv infection
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039888 Methods Of Inhibiting Inflammation-Associated Tissue Damage By Inhibiting Neutrophil Activity
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039882 Vascular Disease Therapies
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039872 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks
02/16/2012US20120039866 Methods of treating pain
02/16/2012US20120039865 Identification of sortilin as a neuronal receptor for the frontotemporal dementia protein, progranulin
02/16/2012US20120039851 Use of androgens for vascular regeneration and endothelial repair
02/16/2012US20120039849 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
02/16/2012US20120039848 Hepatitis c virus inhibitors
02/16/2012US20120039847 Hepatitis C Virus Inhibitors
02/16/2012US20120039845 Nucleoside prodrugs and uses thereof
02/16/2012US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation
02/16/2012US20120039839 Hypoxia Induced Mitogenic Factor
02/16/2012US20120039838 Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin
02/16/2012US20120039825 Phototherapy compositions and methods
02/16/2012US20120039823 Preparations for reducing itching and other paraesthesias with (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethylcyclohexanecarboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexanecarboxamide and/or (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2isopropyl-5-methylcyclohexanecarboxamide
02/16/2012US20120039820 Antibacterial composition comprising 4-isopropyl-3-methylphenol and zinc ions
02/16/2012US20120039810 Aptamer-containing compositions and methods for targeting e-selectin
02/16/2012US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
02/16/2012US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors
02/16/2012US20120039803 Pretargeting kit, method and agents used therein
02/16/2012US20120039800 Platinum Acridine Anti-Cancer Compounds And Methods Thereof
02/16/2012US20120039799 Viral nanoparticle cell-targeted delivery platform
02/16/2012US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients
02/16/2012US20120038073 Spray drying methods and related compositions
02/16/2012DE102009007771B4 Bukkales Applikationssystem, 17α-Estradiol enthaltend Buccal delivery system, 17α-estradiol containing
02/16/2012CA2848342A1 Acylsulfonamides and processes for producing the same
02/16/2012CA2808435A1 Heterocyclic compound
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 7860